The Scandion Oncology PCT application “WO2020049139 – UREA DERIVATIVES FOR USE IN THE TREATMENT OF SUBJECTS WITH ELEVATED EXPRESSION AND/OR ACTIVITY OF SRPK1” with the Publication Number WO/2020/049139 has been published.
The International Application No. is “PCT/EP2019/073796” and the PCT application relates to treatment of diseases characterized by elevated expression and/or activity of SRPK1 with specific SRPK1 inhibitors and to methods for identifying subjects who may benefit from such treatment.
The PCT application can be viewed here: https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2020049139&tab=PCTDESCRIPTION